<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26522762</article-id>
      <article-id pub-id-type="pmc">4697346</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2016.36.1.64</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
          <subj-group subj-group-type="subheading">
            <subject>Diagnostic Hematology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Rare Case of Pediatric T Lymphoblastic Leukemia With t(11;17)(q23;q21) Involving Mixed-Lineage Leukemia Gene Rearrangement</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Heyjin</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jin Kyung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jun Ah</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hong</surname>
            <given-names>Young Jun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hong</surname>
            <given-names>Seok-Il</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jo</surname>
            <given-names>Heui Seung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Chang</surname>
            <given-names>Yoon Hwan</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, Korea Cancer Center Hospital, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea.</aff>
      <aff id="A3"><label>3</label>Radiological &amp; Medico-Oncological Sciences, University of Science and Technology, Daejeon, Korea.</aff>
      <aff id="A4"><label>4</label>Department of Pediatrics, CHA Bundang Medical Center, CHA University, Seongnam, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Yoon Hwan Chang. Department of Laboratory Medicine, Korea Cancer Center Hospital, Radiological &amp; Medico-Oncological Sciences, University of Science and Technology, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea. Tel: +82-2-970-1283, Fax: +82-2-973-7143, <email>cyhlabo@kcch.re.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <volume>36</volume>
      <issue>1</issue>
      <fpage>64</fpage>
      <lpage>66</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>17</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>T lymphoblastic leukemia (T-ALL) comprises 10-15% of pediatric ALL cases and is known to be a clinically and genetically heterogeneous disease [<xref rid="B1" ref-type="bibr">1</xref>]. Recent studies have presented various cytogenetic abnormalities in T-ALL. The alterations often present as reciprocal translocations implicated in several transcriptional factor genes and lead to arrest during T-cell differentiation [<xref rid="B1" ref-type="bibr">1</xref><xref rid="B2" ref-type="bibr">2</xref>]. Although cytogenetic aberrations are known to be critical in leukemogenesis of many hematologic malignancies, the relationships between these aberrations and the prognosis are not well understood in T-ALL except for t(11;19), a mixed-lineage leukemia gene <italic>(MLL)-ENL</italic> fusion related to favorable prognosis [<xref rid="B3" ref-type="bibr">3</xref>]. Here, we report a very rare case of pediatric T-ALL with t(11;17)(q23;q21) involving <italic>MLL</italic> rearrangement, which has not been previously reported in Korea.</p>
    <p>A 16-month-old boy was admitted to our hospital because of fever, cough, rhinorrhea, and poor oral intake. Physical examination revealed anemic conjunctiva, cervical lymph node enlargement, and splenomegaly. Chest radiography showed no abnormal findings. The complete blood count (CBC) results were as follows: hemoglobin, 8.2 g/dL; leukocytes, 41.3&#xD7;10<sup>9</sup>/L; platelets, 177&#xD7;10<sup>9</sup>/L; and reticulocyte count, 3.4%. The blood smear showed increased blasts (66%). The bone marrow (BM) specimen contained 65% blasts and showed a hypercellular pattern. Small-to-medium sized blasts were observed with condensed nuclear chromatin and an irregular nuclei margin. Immunophenotyping using the BM aspirate was brightly positive for CD2 (86%), cCD3 (91%), CD5 (91%), CD7 (92%), and CD34 (76%). Serum lactate dehydrogenase was increased to 638 IU/L. Cytogenetic studies on the BM revealed the karyotype of 46,XY,t(11;17)(q23;q21)[17]/46,XY[3] (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). The patient was diagnosed with T-ALL according to the 2008 WHO classification [<xref rid="B4" ref-type="bibr">4</xref>].</p>
    <p>The patient began receiving induction chemotherapy comprised of prednisolone, vincristine, L-asparaginase, intrathecal cytosine arabinoside, and methotrexate. He seemed to respond to chemotherapy, with decreasing leukocyte counts and spleen size. However, the BM aspirate performed on the 7th day showed increased blasts to 69%. Moreover, interphase FISH analysis using an 11q23 break-apart probe revealed <italic>MLL</italic> rearrangement (158 of 200, 79%) (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). He was switched to more intensive induction chemotherapy including doxorubicin and cyclophosphamide. The patient achieved complete remission after 28 days of re-induction chemotherapy. Because of his high-risk features, the patient received cord blood stem cell transplantation. At the time of writing, he is alive and has been in a continuous complete remission state for 26 months.</p>
    <p><italic>MLL</italic>/11q23 rearrangement is intricate in many hematologic malignancies such as ALL, AML, and MDS. The 11q23 translocation, which is rarely identified in T-ALL, is a distinct subtype characterized by differentiation arrest at an early stage of thymocyte differentiation [<xref rid="B5" ref-type="bibr">5</xref>]. Since <italic>MLL</italic> fusion partners are also known to have an important role in leukemogenesis, recent efforts to unravel <italic>MLL</italic> fusion partners using long-distance inverse-PCR (LDI-PCR) as compensatory diagnostic method have been implemented by using current molecular diagnostic tools [<xref rid="B6" ref-type="bibr">6</xref><xref rid="B7" ref-type="bibr">7</xref>]. Not only scarce <italic>MLL</italic> rearrangement but also few fusion genes are involved in T-ALL, despite that 79 different <italic>MLL</italic> fusion partner genes have been identified in other hematologic malignancies [<xref rid="B6" ref-type="bibr">6</xref><xref rid="B8" ref-type="bibr">8</xref>].</p>
    <p>When balanced t(11;17)(q23;q21) involving <italic>MLL</italic> rearrangement was searched on the molecular level, three different fusions with <italic>MLL</italic> at 11q23 were generated by proximally clustered genes at the same chromosomal loci: <italic>MLLT6/AF17</italic>, <italic>ACACA</italic>, and <italic>LASP1</italic> at 17q21 [<xref rid="B8" ref-type="bibr">8</xref>]. Thus far, <italic>MLL</italic> with each of the other three fusion partner genes at 17q21 has been identified mainly in AML and rarely in ALL [<xref rid="B8" ref-type="bibr">8</xref>]. Unfortunately, the fusion partner gene in this case could not be confirmed by using LDI-PCR because of specimen problems. A literature search revealed only two cases regarding t(11;17)(q23;q21) in adults with T-ALL [<xref rid="B9" ref-type="bibr">9</xref><xref rid="B10" ref-type="bibr">10</xref>] (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
    <p>Prior studies have suggested that immunophenotypic markers are correlated with genetic alterations in pediatric acute leukemia [<xref rid="B2" ref-type="bibr">2</xref>]. The immunophenotype of leukemic cells in our patient could be classified into the pre-T stage and immature stage according to the European Group for the Immunological Characterization of Leukaemias and T-cell receptor classification system [<xref rid="B2" ref-type="bibr">2</xref>]. The immature stage of T-ALL was reported with respect to poor outcome and the lack of a common genetic lesion [<xref rid="B1" ref-type="bibr">1</xref><xref rid="B2" ref-type="bibr">2</xref>]. In several studies, <italic>MLL</italic>-rearranged T-ALL overexpressed multiple HOX, which are transcription factors that initiate T-cell differentiation [<xref rid="B5" ref-type="bibr">5</xref>].</p>
    <p>Additional cases involving genetic profiling of t(11;17)(q23; q21) involving <italic>MLL</italic> rearrangement will help assess whether this rare fusion impacts the disease progression and reveals prognostic information.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Authors' Disclosures of Potential Conflicts of Interest:</bold> No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patrick</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vora</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Update on biology and treatment of T-cell acute lymphoblastic leukaemia</article-title>
          <source>Curr Opin Pediatr</source>
          <year>2015</year>
          <volume>27</volume>
          <fpage>44</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">25502893</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meijerink</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia</article-title>
          <source>Best Pract Res Clin Haematol</source>
          <year>2010</year>
          <volume>23</volume>
          <fpage>307</fpage>
          <lpage>318</lpage>
          <pub-id pub-id-type="pmid">21112032</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pui</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Schrappe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Niemeyer</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Childhood and adolescent lymphoid and myeloid leukemia</article-title>
          <source>Hematology Am Soc Hematol Educ Program</source>
          <year>2004</year>
          <fpage>118</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="pmid">15561680</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Borowitz</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>JKC</given-names>
            </name>
          </person-group>
          <chapter-title>T lymphoblastic leukaemia/lymphoma</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Pileri</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <source>WHO classification of tumours of haematopoietic and lymphoid tissues</source>
          <edition>4th ed</edition>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC</publisher-name>
          <year>2008</year>
          <fpage>176</fpage>
          <lpage>178</lpage>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrando</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Neuberg</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Sallan</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Silverman</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Korsmeyer</surname>
              <given-names>SJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation</article-title>
          <source>Blood</source>
          <year>2003</year>
          <volume>102</volume>
          <fpage>262</fpage>
          <lpage>268</lpage>
          <pub-id pub-id-type="pmid">12637319</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hofmann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Burmeister</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gr&#xF6;ger</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Emerenciano</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The MLL recombinome of acute leukemias in 2013</article-title>
          <source>Leukemia</source>
          <year>2013</year>
          <volume>27</volume>
          <fpage>2165</fpage>
          <lpage>2176</lpage>
          <pub-id pub-id-type="pmid">23628958</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Marschalek</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <article-title>Diagnostic usefulness of genomic breakpoint analysis of various gene rearrangements in acute leukemias: a perspective of long distance- or long distance inverse-PCR-based approaches</article-title>
          <source>Ann Lab Med</source>
          <year>2012</year>
          <volume>32</volume>
          <fpage>316</fpage>
          <lpage>318</lpage>
          <pub-id pub-id-type="pmid">22779077</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strehl</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>K&#xF6;nig</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Harbott</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>J&#xE4;ger</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>2006</year>
          <volume>45</volume>
          <fpage>1041</fpage>
          <lpage>1049</lpage>
          <pub-id pub-id-type="pmid">16897742</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrison</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Cuneo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lafage-Pochitaloff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mugneret</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants</article-title>
          <source>Leukemia</source>
          <year>1998</year>
          <volume>12</volume>
          <fpage>811</fpage>
          <lpage>822</lpage>
          <pub-id pub-id-type="pmid">9593286</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beverstock</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Hoekman</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kluin-Nelemans</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Wienhofer</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Reciprocal translocation, t(11;17)(q23-25;q21), in a patient with an immature ALL</article-title>
          <source>Cancer Genet Cytogenet</source>
          <year>1986</year>
          <volume>22</volume>
          <fpage>83</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">3456831</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <title>Bone marrow karyogram at diagnosis and interphase FISH analysis after induction chemotherapy. (A) G-banded karyogram showing t(11;17)(q23;q21). The arrows denote the rearranged chromosomes. (B) FISH analysis using 11q23 break-apart probe revealed <italic>MLL</italic> rearrangement (158/200, 79%). Separation of a green and a red signal was observed.</title>
      </caption>
      <graphic xlink:href="alm-36-64-g001"/>
    </fig>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <title>Reported cases of T-ALL with t(11;17)(q23;q21)</title>
      </caption>
      <alternatives>
        <graphic xlink:href="alm-36-64-i001"/>
        <table frame="hsides" rules="rows">
          <thead>
            <tr>
              <th valign="middle" align="center" rowspan="1" colspan="1">Case No.</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Age/sex</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Leukocytes (&#xD7;10<sup>9</sup>/L)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Hb (g/dL)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Platelets (&#xD7; 10<sup>9</sup>/L)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Blasts in PB (%)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Karyotypes</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Immunophenotypes</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">OS (mo)</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Country</th>
              <th valign="middle" align="center" rowspan="1" colspan="1">Reference</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">1</td>
              <td valign="top" align="center" rowspan="1" colspan="1">52 yr/F</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.05</td>
              <td valign="top" align="center" rowspan="1" colspan="1">8.4</td>
              <td valign="top" align="center" rowspan="1" colspan="1">0.08</td>
              <td valign="top" align="center" rowspan="1" colspan="1">68</td>
              <td valign="top" align="left" rowspan="1" colspan="1">46,XX,t(11;17) (q23-25;q21)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CD7(+), OKT10(+), CD1(-), CD3(-), CD4(-), CD8(-), CD10(-), CD19(-), anti-HLA-DR(-), 63D3(-), and TdT(-)<sup>*</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt; 14.5</td>
              <td valign="top" align="center" rowspan="1" colspan="1">the Netherlands</td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <xref rid="B9" ref-type="bibr">9</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">49 yr/M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
              <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
              <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
              <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
              <td valign="top" align="left" rowspan="1" colspan="1">46,XY,t(11;17) (q23;q21)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
              <td valign="top" align="center" rowspan="1" colspan="1">11.6<sup>&#x2020;</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">EU<sup>&#x2021;</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">
                <xref rid="B10" ref-type="bibr">10</xref>
              </td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">16 mo/M</td>
              <td valign="top" align="center" rowspan="1" colspan="1">41.3</td>
              <td valign="top" align="center" rowspan="1" colspan="1">8.2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">177</td>
              <td valign="top" align="center" rowspan="1" colspan="1">66</td>
              <td valign="top" align="left" rowspan="1" colspan="1">46,XY,t(11;17)(q23;q21)[17]/46,XY[3]</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CD2 (86%), cCD3 (91%), CD5 (91%), CD7 (92%), and CD34 (76%)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;26.4<sup>&#x2020;</sup></td>
              <td valign="top" align="center" rowspan="1" colspan="1">Korea</td>
              <td valign="top" align="center" rowspan="1" colspan="1">Present case</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn>
          <p><sup>*</sup>The results were performed with immunohistochemical stain; <sup>&#x2020;</sup>The patients received bone marrow transplantation; <sup>&#x2021;</sup>The European 11q23 Workshop participants.</p>
          <p>Abbreviations: T-ALL, T lymphoblastic leukemia; PB, peripheral blood; OS, overall survival; F, female; CD, cluster of differentiation; TdT, terminal deoxynucleotidyl transferase; M, male; ND, no data; EU, European Union; mo, months.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
